Dr. Gerlinde Wernig, MD

Dr. Wernig practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Wernig's NPI, 1609049741, was assigned on April 9, 2008. Dr. Wernig graduated from University of Vienna Faculty of Medicine in 1999. Dr. Wernig holds California license A119554.

Dr. Wernig's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Wernig's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Wernig to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Wernig's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wernig practices, 4 sites in all. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Wernig's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Wernig is board certified in hematopathology by the American Board of Pathology. Dr. Wernig is licensed in California.

CMS data shows 19 Medicare services from Dr. Wernig across 1 procedure code in 2024, for 18 Medicare patients. Medicare paid $1,426 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 18 Medicare patients who saw Dr. Wernig in 2024. 72% of them have high blood pressure, and 61% have high cholesterol. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wernig's median patient age at 59, with 51% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Wernig for performance year 2024, reported as part of a group. Dr. Wernig accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Wernig, published from 2005 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Disease Models, Animal, Signal Transduction and Janus Kinase 2. Dr. Wernig has published most often in Proc Natl Acad Sci U S A. Dr. Wernig's most frequent co-authors are Deshka Stonorov Foster, MD, Michael Thornton Longaker, MBA, MD and Clement Douglass Marshall, MD.

CMS Open Payments shows 4 general payments to Dr. Wernig from 1 drug or device company from 2018 to 2020. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $98.

Dr. Wernig graduated from University of Vienna Faculty of Medicine in 1999.

Dr. Wernig is in network with 2 carriers, including CMS Medicare and NV State Medicaid. Medicaid plans come from the most carriers, 1. Check the plan with the practice before a visit.